Two Sigma Securities’s Standard BioTools LAB Stock Holding History

Two Sigma Securities’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,599	Closed	-$18.7K	–	1744
2025 Q2	$18.7K	Buy	+15,599	New	+$17.3K	﹤0.01%	1221
2025 Q1	–	Sell	-17,341	Closed	-$30.3K	–	1869
2024 Q4	$30.3K	Buy	+17,341	New	+$32.3K	﹤0.01%	1250
2024 Q3	–	Sell	-27,230	Closed	-$48.2K	–	3286
2024 Q2	$48.2K	Buy	27,230 +11,006	+68%	+$26.9K	﹤0.01%	2577
2024 Q1	$44K	Sell	16,224 -3,730	-19%	-$9.01K	﹤0.01%	2584
2023 Q4	$44.1K	Buy	+19,954	New	+$42.6K	﹤0.01%	2621
2023 Q2	–	Sell	-11,014	Closed	-$21.5K	–	3096
2023 Q1	$21.5K	Buy	+11,014	New	+$21.8K	﹤0.01%	2352
2022 Q3	–	Sell	-11,564	Closed	-$19K	–	2878
2022 Q2	$19K	Buy	+11,564	New	+$28.6K	﹤0.01%	1966

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Two Sigma Securities's LAB Position: Q3 2025 in Review

Two Sigma Securities sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 15,599 shares — an estimated $18.7K sold.

Two Sigma Securities first reported a position in LAB in Q2 2022 and held it in 7 quarters. The position peaked at $48.2K in Q2 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

Two Sigma Securities reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 15,599 Standard BioTools shares in Q3 2025, an estimated $18.7K.
Two Sigma Securities first reported a position in Standard BioTools in Q2 2022 and held it in 7 quarters.
Two Sigma Securities's Standard BioTools position peaked at $48.2K in Q2 2024.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.